banner
Reference Listed Drugs
Fabrazyme 5mg 35mg Agalsidase Beta For Injection Reference Listed Drug

Fabrazyme 5mg 35mg Agalsidase Beta For Injection Reference Listed Drug

Fabrazyme is indicated for long-term enzyme replacement therapy in patients diagnosed with Fabry disease (alpha-galactosidase A deficiency). For R&D purposes only.

Product Details

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

 

Generic name Agalsidase Beta for Injection
Trade name Fabrazyme
Specification

5mg/vial

35mg/vial

Main ingredients Agalsidase Beta
Appearance White or white - like freeze-dried lump or powder.
MA Holder Genzyme Europe B.V.
Manufacturer Genzyme Ireland Limited
Indications

 

Fabrazyme is indicated for long-term enzyme replacement therapy in patients diagnosed with Fabry disease (alpha-galactosidase A deficiency).


It is suitable for adults, children 8 years old and above, and teenagers.

 

 

 

Fabrazyme

Fabrazyme-2

Fabrazyme-3

Fabrazyme-4

 

 

For more details,pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

Hot Tags: Fabrazyme 5mg 35mg Agalsidase Beta For Injection Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Acarbose Tablets, Olanzapine Tablets, Phenytoin Sodium Tablets, Reference Listed Drugs, AdapaleneGel, Alfacalcidol Soft Capsules

Send Inquiry
Verification Code: